In the BioHarmony Drug Report Database
Vincristine
Marqibo, Oncovin (vincristine) is a small molecule pharmaceutical. Vincristine was first approved as Marqibo on 1982-01-01. It is used to treat hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, and rhabdomyosarcoma amongst others in the USA. The pharmaceutical is active against tubulin beta chain.
Trade Name
|
Marqibo, Oncovin |
|---|---|
Common Name
|
vincristine |
ChEMBL ID
|
CHEMBL90555 |
Indication
|
hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, rhabdomyosarcoma, wilms tumor |
Drug Class
|
Vinca alkaloids |
Image (chem structure or protein)